Money Matters magazine has named us in its top 50 ‘sound investments’ two years running.
A 2006 Eduwatch survey of postgraduate students placed us in the top 10 of most desirable private sector employers for science graduates.
Since 2003 New Eden’s projects have generated over 1,500 column inches in the national press.
In 2007, a major industry survey conducted by U-Know gave us an ‘excellent’ ranking for our standards of integrity and environmental awareness.
Gull’s Medical Journal voted Lexaran (developed by New Eden) the most significant new medical product of 2005.
Please click the play button above to see New Eden's Application for European Research Funding, presented by our CEO, Dr. John Winters.
New Eden - Copyright © 2008 - All Rights Reserved About this Site Terms of Use